September 26, 2007
Sonus Pharmaceuticals, Inc. (NASDAQ:SNUS) announced that its Phase 3 pivotal trial of TOCOSOL(R) Paclitaxel in women with metastatic breast cancer did not meet its primary endpoint of non-inferiority on objective response rate (ORR) when compared to the Taxol(R) control arm. Trial results showed the ORR for TOCOSOL Paclitaxel was 37% versus 45% for Taxol (p value = 0.085). The outcome of this trial does not support the submission of a New Drug Application. [click link for full article]
A study that will use a simple eye test to save the lives and limbs of diabetics is one of seven QUT projects funded in the latest round of National Health and Medical Research Council grants.Research Professor Nathan Efron will use a breakthrough technique to develop the use of an optical instrument capable of looking at the cornea - the clear window at the front of the eye - under high magnification to assess a painful condition known as diabetic neuropathy. [click link for full article]
Empowering chronic pain sufferers and their practitioners, The Journey to Pain Relief describes an innovative pain management approach that taps into the body’s inherent ability to heal. [click link for full article]
The Cardinal Orthopaedic Institutes’ Kenneth J. Westerheide, MD is one of the only Ohio surgeons trained to perform a new outpatient procedure called hip arthroscopy. For those suffering from serious hip pain, this procedure may postpone the need for hip replacement surgery or eliminate it altogether. Dr. Westerheide recently performed arthroscopy on both hips of Ohio kindergarten teacher Helen Raines. [click link for full article]
The American Public Health Association (APHA) urges all members of the House and Senate to vote in favor of pending legislation to reauthorize the Children’s Health Insurance Program (CHIP).The CHIP legislation that is up for vote in Congress is the result of intense negotiations and represents a bipartisan compromise aimed at protecting the health of those children most in need. The legislation will preserve health coverage for the nearly 6. [click link for full article]
New data show that the addition of Herceptin® (trastuzumab) to chemotherapy prior to breast cancer surgery (neoadjuvant therapy) completely eradicates tumours in nearly three times as many women with inflammatory HER2-positive breast cancer compared to chemotherapy alone. Inflammatory breast cancer is a rare, but highly aggressive form of the disease - the tumours spread quickly, often leading to the need for full mastectomies, and it has a worse outlook than other breast cancers. [click link for full article]
U.S. House and Senate leaders are meeting this month to work out differences between their separate versions of legislation that reauthorizes the 10-year-old Children’s Health Insurance Program (CHIP). A new report from Families USA spells out how many additional children would be covered in each state under the House and Senate bills. [click link for full article]
The American Society for Therapeutic Radiology and Oncology has published an updated version of its brochure Radiation Therapy for Gynecologic Cancers. The brochure provides women coping with a gynecologic cancer useful information on the different types of radiation therapy and their treatment options, as well as new information on the potential side effects and how to care for themselves while undergoing treatment. [click link for full article]
IMR International Limited, developers of e-communication and clinical information solutions, announced the launch of a comprehensive guide to diabetes within its new public health portal; http://www.epgpatientdirect.org. Supported by Novo Nordisk, the [click link for full article]
Disability Rights Commission report deeply distressing, says learning disability charity Commenting on the health inequalities report released by the Disability Rights Commission, Alison Giraud-Saunders, Co-Director of the Foundation for People with Learning Disabilities charity said: “The findings of this report are deeply distressing. It seems that still, little value is placed on the lives of people with learning disabilities. [click link for full article]